Cargando…
Levosimendan: use, cost-effectiveness and outcome in a tertiary cardiothoracic centre
Autores principales: | Ranjan, A, Bhudia, N, McGovern, I, Walker, C, Kuppurao, L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473041/ http://dx.doi.org/10.1186/cc14232 |
Ejemplares similares
-
Extracorporeal membrane oxygenator (ECMO) and ventricular assist device (VAD) activity of a tertiary cardiothoracic centre: survival rates and length of ITU stay
por: Sarridou, D, et al.
Publicado: (2015) -
Outcomes following repatriation from cardiothoracic intensive care to referring centres
por: Abu Al-Saad, N, et al.
Publicado: (2015) -
Critical care outreach: implementation in a cardiothoracic centre
por: Carbery, C, et al.
Publicado: (2005) -
Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004) -
Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006)